5Stapleton PD, Taylor PW. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation [J]. Sci Prog,2002,85 ( Pt 1 ) : 57-72.
6Hiramatsu K, Katayama Y, Yuzawa H, et al. Molecular genetics of methicillin-resistant Staphylococcus aureus [J]. Int J Med Microbiol, 2002,292 ( 2 ) : 67-74.
8Tokue Y,Shoji S, Satoh K,et al. Comparison of a PCR assay and a conventional microbiologic method for detection of MRSA [J ].Antimicrob Agens Chemother, 1992,36 ( 1 ) : 6-9.
9Deurenberg RH , Kalenic CVS, A.Friedrich W, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus [J]. Clin Microbiol Infect,2007,13: 222-235.
10Jansen WT, Beitsma MM, Koeman CJ, et al. Novel mobile variants of Staphylococcal cassette chromosome mec in Staphylococcus aureus [ J]. Antimicrob Agents Chemother, 2006, 50(6 ) : 2072-2078,
二级参考文献25
1Hiramatsu K,Katayama Y, Yuzawa H, et al. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol, 2002,292 ( 2 ) : 67-74.
2Bo Shopsin, Barry N. Kreiswirth. Molecular epidemiology of methicillin-resistant Staphylococcus aureus. Emerg Infect Dis,2001,7(2) : 323-326.
3Mark C. Enright D. Ashley Robinson,Gaynor Randle,Edward J.Feil, Hajo Grundmann, and Brian G. Spratt The evolutionary history of methieillin-resistant Staphylococcus aureus (MRSA).PNAS,2002,99(11) :7687-7692.
4Nafsika H. Georgopapadakou. Infectious disease 2001: drug resistance, new drugs. Drug resistance updates, 2002,5 : 181-191.
5Soju Chang, Dawn MS, Jeffrey C, et al. For the Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with Vancomycin-Resistant Staphylococcus aureus containing the vanA Resistance Gene. New Engl J Med, 2003,348 (14) : 1342-1347.
7Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerging Infectious Diseases,2001,7(2) : 178-182.
8Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Communityacquired methicillin-resistant Staphylococcus aureus, Finland.Emerg Infect Dis, 2002,8 (6) : 602-607.
9Linares J. The VISA/GISA problem: therapeutic implications Clin Microbiol Infect,2001,7(Suppl 4) :8-15.
10Lecaillon E, Gueudet P, Wooton M, et al. Endemic heteroresistant glycopeptide intermediate Staphylcoccus aureus(hGISA) comprising unrelated clonal types and not associated with vancomycin therapy. Pathol Biol (Paris), 2002,50(9) : 525-529.
